Immunotherapeutic potential of bispecific antibodies.
van de Winkel
J G
JG
Dept of Immunology, University Hospital Utrecht, The Netherlands. J.vandeWinkel@lab.azu.nl
Bast
B
B
de Gast
G C
GC
D018033:Antibodies, Bispecific / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D001402:B-Lymphocytes / Q000276:immunology; D002986:Clinical Trials as Topic; D003141:Communicable Diseases / Q000628:therapy*; D004730:Endothelium, Vascular / Q000276:immunology; D006801:Humans; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D017452:Receptors, IgG / Q000276:immunology
D018033:Antibodies, Bispecific; D011948:Receptors, Antigen, T-Cell; D017452:Receptors, IgG